A5013155819- Health Systems, Economic Evaluations, Quality of Life
- Atrial Fibrillation Management and Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Venous Thromboembolism Diagnosis and Management
- Antibiotic Use and Resistance
- Cardiac electrophysiology and arrhythmias
- Health and Medical Research Impacts
- Heparin-Induced Thrombocytopenia and Thrombosis
- Lipoproteins and Cardiovascular Health
- Tuberculosis Research and Epidemiology
- ECG Monitoring and Analysis
- Blood Pressure and Hypertension Studies
Burapha University
2021-2023
Drug-induced corrected QT (QTc) prolongation can cause Torsade de Pointes (TdP) which leads to severe arrhythmia or sudden cardiac death. However, information on the prevalence of QTc in coronavirus disease 2019 (COVID-19) patients and risk factors is limited. A retrospective chart review was conducted COVID-19 admitted Chonburi Hospital from April October 2020. The outcomes were incidence factor prolongation. We included 29 patients. After treatments initiated, occurred 17 (58.62%). could...
Complex dosage regimens and the high incidence of adverse events associated with warfarin therapy can affect health-related quality life (HRQoL) willingness to pay (WTP) among patients on warfarin. No such previous study has been conducted assess HRQoL WTP Thai warfarin; therefore, this aimed measure these parameters identify some sociodemographic factors those aspects in Thailand.This cross-sectional survey involving 260 between June 2022 2023 used a quantitative method for data collection....
World Health Organization (WHO) released the treatment manual of diarrhea in 2005. We aimed to investigate rationale for selecting medications acute infective Thai community pharmacies and see if selection complied with WHO manual. A theoretical 18-year-old patient was used interviews. The protocol materials research were approved by Institutional Review Board. total 30 drugstore personnel selected convenience sampling included. first author manually coded, extracted themes, translated...
Initiating favipiravir in COVID-19 patients with long-term warfarin use can lead to increased INR. However, data on the onset and duration of increasing INR are limited.